Formulation design, development and characterization of dexibuprofen emulgel for topical delivery: In-vitro and In-vivo evaluation

IN-VITRO AND IN-VIVO EVALUATION

  • Vijay Rajaram Mahajan Research Scholar, Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India
  • Ganesh Dinkar Basarkar Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India

Abstract

Emulgels have emerged as a promising drug delivery system for the delivery of hydrophobic drugs. The objective of the study was to prepare emulgel of Dexibuprofen, a NSAID, using Carbapol 940 as a gelling agent. Clove oil and Mentha oil were used as penetration enhancers. The emulsion was prepared and it was added in gel base. The formulations were evaluated for rheological studies, spreading coefficient studies, bioadhesion strength, skin irritation studies, in vitro release, ex vivo release studies, anti-inflammatory activity and analgesic activity. Formulation showed comparable analgesic and anti-inflammatory activity when they compared with marketed diclofenac sodium gel. So, it can be concluded that topical emulgel of Dexibuprofen possess an effective anti-inflammatory and analgesic activity.


Keywords: Emulgel, Dexibuprofen, Topical Drug Delivery, bioavailability, NSAIDs

Downloads

Download data is not yet available.

Author Biographies

Vijay Rajaram Mahajan, Research Scholar, Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India

Research Scholar, Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India

Ganesh Dinkar Basarkar, Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India

Department of Pharmaceutics, SSDJ College of Pharmacy, Chandwad, Nashik, (M.S.) India

References

1. Gennaro AR, Remington: the Science and Practice of Pharmacy. 19th ed. Mack Publishing Company; Easton.1995.
2. Ansel HC, Allen LV, Popovich NG, Pharmaceutical Dosage Forms and Drug Delivery Systems. 7th ed. Lippincott Williams and Wilkins; New York. 1999.
3. Rieger MM, Lachman L, Lieberman HA, Kaing JL, The theory and practice of industrial pharmacy. 3 rd ed. PA Lea and Febiger; Philadelphia; 1986. 502-533.
4. Khullar R, Saini S, Seth N, Rana AC, Emulgels: A Surrogate Approach For Topically Used Hydrophobic Drugs, International Journal of Pharmacy and Biological Sciences, 2011; 1(3):117-128.
5. Jain A, Deveda P, Vyas N, Chauhan J, Development of antifungal emulsion based gel for topical fungal infection, International Journal of Pharmaceutical Research and Development, 2011; 2: 03.
6. Kasliwal N, Derle D, Negi J, Gohil J, Effect of permeation enhancers on the release and permeationkinetics of meloxicam gel formulations through rat skin, Asian Journal of Pharmaceutical Sciences, 2008; 3(5):193–199.
7. Bonacucina G, Cespi M, Palmieri GF, Characterization and stability of emulsion gels based on acrylamide/sodium acryloyldimethyl taurate copolymer, AAPS PharmSciTech, 2005; 2: 10.
8. Gupta GD, Gaud RS, Release rate of tenoxicam from acrypol gels, Industrial Pharmacy, 2005; 69-76.
9. Murty SN, Hiremath SR. Physical and chemical enhancers in transdermal delivery of terbutaline sulphate. AAPS Pharm. Sci. Tech., 2001; 2: 1-5.
10. Choi HG, Yong CS, Sah H, Jahng Y, Chang HW, Son JK, Lee SH, Jeong TC, Rhee JD, Baek SH, Physiochemical characterization of diclofenac sodium loaded poloxamer gels as a rectal delivery system with fast absorption,. Drug Development and Industrial Pharmacy, 2003; 29: 545-553.
11. Kakkar AP, Gupta A, Gelatin based transdermal therapeutic system, Indian Drugs, 1992; 29:308-312.
12. Schreier H, Bouwstra JA, Liposomes and Niosomes as topical drug carriers: Dermal and Transdermal delivery, Journal of Controlled Release, 1985; 30:863-868.
13. Crunkhorn P, Mencock SC, Mediators of inflammation induced in rat paw carregeenan. British Journal of Pharmacology, 1971; 42:371-402.
14. ICH Harmonized Tripartite Guidelines, Stability Testing of New Drug Substances and Products. ICH Committee, 2003; 8.
15. Mohamed MI, Optimization of chlorphenesin emulgel formulation, AAPS J, 2004; 6:3.
16. Lionberge DR, Brennan MJ, Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch, Journal of Pain Research, 2010; 3:223 - 233.
17. Stanos SP, Topical agents for the management of musculoskeletal pain. J. Pain Symptomatic Management, 2007; 33.
18. Gupta A, Mishra AK, Singh AK, Gupta V, Bansal P, Formulation and evaluation of topical gel of diclofenac sodium using different polymers, Drug Invention Today, 2010; 2:250-253.
19. Kumar L, Verma R, In vitro evaluation of topical gel prepared using natural polymer, International Journal of Drug Delivery, 2010; 2:58-63.
20. Lionberger DR, Brennan MJ, Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch, Journal of Pain Research, 2010; 3:223- 233.
Statistics
32 Views | 25 Downloads
How to Cite
Mahajan, V., & Basarkar, G. D. (2019). Formulation design, development and characterization of dexibuprofen emulgel for topical delivery: In-vitro and In-vivo evaluation. Journal of Drug Delivery and Therapeutics, 9(2-s), 330-342. https://doi.org/10.22270/jddt.v9i2-s.2711